EdgarLookup

CRESCENT BIOPHARMA, INC. — All Filings

625 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-Q 144 3 4 4/A 424B3 424B4 424B5 425 5 8-A12B 8-A12B/A 8-K ARS CERTNAS CORRESP CT ORDER D D/A DEF 14A DEFA14A DRS EFFECT FWP POS AM POS EX PRE 14A REGDEX S-1 S-1/A S-3 S-4 S-4 POS S-4/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
8-A12B FORM 8-A12B 0001193125-13-427608 Nov 5, 2013
CORRESP 0001193125-13-427598 Nov 5, 2013
CORRESP 0001193125-13-427591 Nov 5, 2013
S-1/A AMENDMENT NO. 2 TO FORM S-1 0001193125-13-421071 Oct 31, 2013
S-1/A AMENDMENT NO. 1 TO FORM S-1 0001193125-13-412381 Oct 28, 2013
CORRESP 0001193125-13-408207 Oct 23, 2013
CORRESP 0001193125-13-404114 Oct 18, 2013
UPLOAD 0000000000-13-057120 Oct 17, 2013
S-1 FORM S-1 0001193125-13-391443 Oct 4, 2013
UPLOAD 0000000000-13-051720 Sep 19, 2013
DRS 0000950123-13-007128 Aug 21, 2013
D/A 0001140361-10-042357 Oct 27, 2010
D 0001140361-09-024718 Nov 4, 2009
D 0001140361-09-024717 Nov 4, 2009
REGDEX AUTO-GENERATED PAPER DOCUMENT 9999999997-06-033723 Jul 13, 2006
REGDEX AUTO-GENERATED PAPER DOCUMENT 9999999997-03-028983 Jul 10, 2003